AKT1 and neoplasm: Next, surprisingly, researchers discovered that PtdSer potentiates the effects of PD-L1 signaling to T cells, thus proving the existence of a PtdSer-TAM-PD-L1-PI3k/Akt signaling axis in breast cancer, which contributes to tumor immune escape and chemoresistance [60].